Skip to main content

Advertisement

SpringerLink
Log in

GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

GATA1, a member of the GATA transcription factor family, was reported to play a role in development and progression of erythroid cells and breast cancer cells. However, the role of GATA1 in colorectal cancer (CRC) is unknown. Here, we demonstrate that GATA1 was upregulated in CRC tissues compared with normal tissues, and predicted poor clinical outcome in CRC. Biological functional analyses showed that GATA1 knockdown decreased CRC cells proliferation, migration and invasion, and regulated the process of epithelial–mesenchymal transition (EMT). Moreover, silencing of GATA1 suppressed colorectal tumor growth in nude mice. Mechanistically, GATA1 overexpression significantly increased the activity of PI3K/AKT signaling pathway in CRC cells. These data provide insight into the important role of GATA1 in CRC progression and suggest that GATA1 is a potential therapeutic target for CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jernal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67:177–193

    Article  PubMed  Google Scholar 

  3. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Ballegooijen MV, Zauber AG, Jemal A (2012) Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev 21:728–736

    Article  PubMed  PubMed Central  Google Scholar 

  4. Imperiale TF, Juluri R, Sherer EA, Glowinski EA, Johnson CS, Morelli MS (2014) A risk index for advanced neoplasia on the second surveillance colonoscopy in patients with previous adenomatous polyps. Gastrointest Endosc 80:471–478

    Article  PubMed  Google Scholar 

  5. Laukoetter MG, Mennigen R, Hannig CM, Osada N, Rijcken E, Vowinkel T, Krieglstein CF, Senninger N, Anthoni C, Bruewer M (2011) Intestinal cancer risk in Crohn’s disease: a meta-analysis. J Gastrointest Surg 15:576–583

    Article  PubMed  Google Scholar 

  6. Cunningham D, Atkin W, Lenz H-J, Lynch HT, Minsky B, Nordlinger B, Starling N (2010) Colorectal cancer. Lancet 375:1030–1047

    Article  PubMed  Google Scholar 

  7. Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B (2015) Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol 54:5–16

    Article  PubMed  Google Scholar 

  8. Boland PM, Ma WW (2017) Immunotherapy for colorectal cancer. Cancers (Basel) 9:50

    Article  CAS  Google Scholar 

  9. Syn NL, Teng MWL, Mok TSK, Soo RA (2017) De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol 18:e731–e741

    Article  PubMed  Google Scholar 

  10. Zheng R, Blobel GA (2010) GATA transcription factors and cancer. Genes Cancer 1:1178–1188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shimizu R, Engel JD, Yamamoto M (2008) GATA1-related leukaemias. Nat Rev Cancer 8:279–287

    Article  CAS  PubMed  Google Scholar 

  12. Boidot R, Vegran F, Jacob D, Chevrier S, Cadouot M, Feron O, Solary E, Lizard-Nacol S (2010) The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism. Oncogene 29:2577–2584

    Article  CAS  PubMed  Google Scholar 

  13. Zhang Y, Liu J, Lin J, Zhou L, Song Y, Wei B, Luo X, Chen Z, Chen Y, Xiong J, Xu X, Ding L, Ye Q (2016) The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer. Oncotarget 7:9859–9875

    PubMed  PubMed Central  Google Scholar 

  14. Li Y, Ke Q, Shao Y, Zhu G, Li Y, Geng N, Jin F, Li F (2015) GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling. Oncotarget 6:4345–4356

    PubMed  PubMed Central  Google Scholar 

  15. Feng Y, Xu X, Zhang Y, Ding J, Wang Y, Zhang X, Wu Z, Kang L, Liang Y, Zhou L, Song S, Zhao K, Ye Q (2015) HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion. Sci Rep 5:9429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. evans T, Reitman M, Felsenfeld G (1988) An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci USA 85:5976–5980

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Krepischi ACV, Maschietto M, Ferreira EN, Silva AG, Costa SS, Cunha IWD, Barros BDF, Grundy PE, Rosenberg C, Carraro DM (2016) Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors. Mol Cytogenet 9:20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Altom DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455–7464

    Article  CAS  Google Scholar 

  19. Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381–395

    Article  CAS  PubMed  Google Scholar 

  20. Xue G, Hemmings BA (2013) PKB/Akt-dependent regulation of cell motility. J Natl Cancer Inst 105:393–404

    Article  CAS  PubMed  Google Scholar 

  21. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, Roy FV, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63:2172–2178

    CAS  PubMed  Google Scholar 

  22. Lamouille S, Derynck R (2007) Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178:437–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pon YL, Zhou HY, Cheung ANY, Ngan HYS, Wong AST (2008) p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res 68:6524–6532

    Article  CAS  PubMed  Google Scholar 

  24. Smith AP, Verrecchia A, Faga G, Doni M, Perna D, Martinato F, Guccione E, Amati B (2009) A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition. Oncogene 28:422–430

    Article  CAS  PubMed  Google Scholar 

  25. Scaltriti M, Baselga J (2006) The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12:5268–5272

    Article  CAS  PubMed  Google Scholar 

  26. Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA (2015) Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta 1855:104–121

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China

    Junhui Yu

  2. Department of Surgery, Beijing Zhanlanlu Hospital, Beijing, 100044, People’s Republic of China

    Ming Liu

  3. Department of Oncology, Huguosi Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100035, People’s Republic of China

    Hui Liu

  4. Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, No 10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, People’s Republic of China

    Lei Zhou

Authors
  1. Junhui Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lei Zhou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All applicable international, national, and institutional guidelines for the care and use of animals were followed.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, J., Liu, M., Liu, H. et al. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway. Mol Cell Biochem 457, 191–199 (2019). https://doi.org/10.1007/s11010-019-03523-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-019-03523-w

Keywords

Search

Navigation